@Article{Giannelli2017,
journal="Journal of Contemporary Brachytherapy",
issn="1689-832X",
volume="9",
number="6",
year="2017",
title="Complete response in a patient with gynecological hidradenocarcinoma treated with exclusive external beam radiotherapy and brachytherapy: a case report",
abstract="Hidradenocarcinoma (HC) is a very rare disease. This case report illustrates a successful treatment of a 60-year-old woman with vulvo-vaginal localization of hidradenocarcinoma treated with external beam radiotherapy delivered by helical tomotherapy with a simultaneous integrated boost (SIB), followed by brachytherapy. External beam radiotherapy dose prescription was 50.4 Gy in 28 fractions, five fractions per week to whole pelvis (planning target volume 1 – PTV1), 60.2 Gy in 28 fractions to SIB1 (fundus of uterus and right inguinal node), and 58.8 Gy in 28 fractions to SIB2 (lower/middle third of vagina, paraurethral region and right inguinal lymph nodes). Brachytherapy dose prescription was 28 Gy in 4 fractions for cervix, fundus of uterus and upper third of vagina (HR-CTV1), and 22 Gy in 4 fractions to middle third of vagina and paraurethral region (HR-CTV2). D90 for whole treatment was 91.9 Gy and 86.0 Gy for HR-CTV1 and HR-CTV2, respectively. Patient remained 12-months disease-free without treatment related side effects.",
author="Giannelli, Flavio
and Chiola, Ilaria
and Belgioia, Liliana
and Garelli, Stefania
and Pastorino, Alice
and Marcenaro, Michela
and Mammoliti, Serafina
and Costantini, Sergio
and Bizzarri, Nicolò
and Vellone, Valerio
and Barra, Salvina
and Corvò, Renzo",
pages="572--578",
doi="10.5114/jcb.2017.71554",
url="http://dx.doi.org/10.5114/jcb.2017.71554"
}